Background and Purpose—The purpose of the present study was to assess whether the direction of flow via the circle of Willis and the ophthalmic artery (OphA) changed over time in patients with a ...

Outlook Therapeutics' Lytenava is the first ophthalmic formulation of bevacizumab to be cleared for use by NICE for use in the NHS for wet AMD.

The first evaluation for subclavian artery occlusive disease should always be a simple measurement of bilateral brachial artery blood pressures. A significant difference between the two ...

Find the latest Ophthalmology news articles, videos, podcasts, and meeting coverage from medical experts and key opinion leaders you trust.

Read current medical research on risk factors, causes and prevention of heart disease, strokes, and peripheral arterial disease. What new treatment options are under development?

Peripheral artery disease (PAD) is a vascular disorder caused by occlusive atherosclerosis, which commonly impairs blood flow to the lower extremities. The prevalence of PAD is increasing globally ...

Ocular Surgery News OSN | Find ophthalmology news articles, videos, blogs, books, Continuing Medical Education (CME), meeting coverage, and journal articles.

Artificial intelligence (AI) based on deep learning (DL) has sparked tremendous global interest in recent years. DL has been widely adopted in image recognition, speech recognition and natural ...